AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the Top 10 Hot Stocks with the Highest Upside Potential. On June 5, AbCellera Biologics Inc. (NASDAQ:ABCL) reported that it has appointed Dr. Victor ...

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the ...

The biomedical company announced plans on Monday to bring 1,200 jobs and relocate 300 jobs from Charlotte to Rock Hill.

In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex ...

A public hearing is scheduled for July 7 on the 1,500-job project at the former Carolina Panthers headquarters construction ...

Mark for the treatment of adult patients with locally advanced pancreatic cancer of exocrine origin, concomitant with gemcitabine and nab-paclitaxel (gem/nab-pac) ...

Quantum Cyber N.V. (Nasdaq:QUCY) is building a vertically integrated autonomous defense platform around top-tier Ukraine-tested combat drones now heading into U.S. production, a ...

Markets have broadly put up strong numbers this year, especially since the late-March stumble that followed the escalation of ...

GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among ...

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the ...

An experimental HIV vaccine trained immune cells to generate broadly neutralizing HIV antibodies in primates. The findings ...